i wish i saw what they see,but based on the action in the stock and im assuming a 12 month target time frame this is very aggressive ,nearly 30 percent.
As part of a summary of changes by research groups released this morning, Leerink raised their WebMD price target to $60 from $55, rating outperform. Shortly after the earnings call last week Leerink had raised the WebMD price target from $54 to $55.
As discussed in my Nov. 4 post, I said that I would not be surprised to see WebMD close the gap created the day after the earnings announcement, where the stock posted a low of $43.53, which was above the previous days high of $41.82. This created a gap on the daily chart of $1.71. As of earlier this morning the stock traded as low as $42.76, reducing the gap to $0.94. For those that follow technicals, one can see that even though, the buy ratings and new estimates for 12 month price target for WebMD being increased to the low $50's, the stock continues to put in lower lows on a daily basis. I don't know if the stock will close the gap at $41.82, but it does bear watching, if you are considering an entry point for buying WebMD.
True,true true....steve......and if something big really is in the works like we all hope for....then it will shoot up in price even quicker if some news comes out.
While no one wants to see the value of their investment decline, there are some benefits to the Income Statements when a company has Convertible Debt and stock buyback objectives. Relative to WebMD, a lower stock price provides an opportunity to buy back that debt closer to par or at just a slight premium as witnessed in the note buy back last qtr. Also, the stock buy back program brings more stock back to the treasury when prices recede. We, the shareholders benefit from these situations, both short term and long term. As the debt and the float are reduced, it has an even greater positive impact on the companies Financials as the Revenue and Profit increase over time, thereby strengthening the Balance Sheet, Cash Flow, Return on Equity Profit per share etc.
Limp, Marty most likely believed that EVDY brought nothing to WebMD that they did not already have, and as a result, may become irrelevant in the future. At some point, advertisers will recognize that their money is better spent with WebMD. EVDY is showing signs of weakening revenue growth and the stock is getting slammed today. If, however, EVDY does possess certain assets that can be acquired at fire sale prices, then, and only then, would Wygod consider the purchase of said assets, but not the entire enterprise.
Steve, I think Marty at one time was offered EVDY, and was not interested.
They always reminded me of Dr.Koop - a lot of noise.
Limp, it was October 2nd 2014 when jakemalloyip said "Now is the time to buy." He was referring to EVDY. He also said, in the same post, that he did not own the stock. If you took his advice and bought EVDY that day, you would have paid between $13.17 and $13.73. Today, EVDY is trading below $7.00.
WebMD was trading, that day, between $36.61 and $39.47. So where is your money better off today?
Based upon the latest EVDY forecast, it appears there best days may be in their rear view mirror!
Who was that guy on this board that recommended to us to throw out WBMD and buy EVDY?
Of course, for our stock we probably have to send a delegation to do some shouting at the Wall of Lamentation...
David Schlanger discussed the opportunity for revenue in India via patient /doctor visits online at the Wells Fargo Healthcare Conference this morning. Drug advertising is not permitted in India Online doctor visits will be introduced in India by WebMD in the near future, according to Schlanger.
I've been following trade alerts from the PennyStock101 free newsletter, These guys have have been right on the money with all of their picks. 524% in real profit with their last 9 picks alone. If you want to get an early jump on the fastest moving NASDAQ and OTC stocks signup now. Forget those overpaid talking heads on CNBc, and google "pennystock101" Best of luck
Tracey, WebMD hit an intra-day high of $48.91 on volume of 1.2 million shares back on April 8th 2015. On that day, the stock closed at $47.99.
the 52 week high was 48.50.i too doubt the stock doesnt give up some gains this afternoon.theres not enough reason for this run up to hold ..for now
I doubt that we will see a close above $45.82 today, as volume usually slows in the afternoon trading of WebMD, and the stock generally trades lower after 12 noon.